Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple sclerosis: emerging opportunities for therapeutic intervention.

C F Evans1, L P Shriver

  • 1Department of Integrative Biology, Digital Gene Technologies, Inc, 11149 North Torrey Pines Road, La Jolla, CA 92037, USA. cevans@dgt.com

Current Drug Targets. CNS and Neurological Disorders
|May 29, 2003
PubMed
Summary

New treatments are needed for multiple sclerosis (MS), a central nervous system demyelinating disease. Gene expression profiling, genomics, and proteomics offer promising avenues for novel therapies and diagnostics to halt MS progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polyamine metabolism impacts T cell dysfunction in the oral mucosa of people living with HIV.

Nature communications·2023
Same author

Inflammation triggers production of dimethylsphingosine from oligodendrocytes.

Neuroscience·2014
Same author

Nanostructure-initiator mass spectrometry (NIMS) imaging of brain cholesterol metabolites in Smith-Lemli-Opitz syndrome.

Neuroscience·2010
Same author

Markers of central nervous system glia and neurons in vivo during normal and pathological conditions.

Current topics in microbiology and immunology·2002
Same author

LCMV and the central nervous system: uncovering basic principles of CNS physiology and virus-induced disease.

Current topics in microbiology and immunology·2002
Same author

In vivo expression of major histocompatibility complex molecules on oligodendrocytes and neurons during viral infection.

The American journal of pathology·2001

Area of Science:

  • Neuroimmunology
  • Central Nervous System Disorders
  • Pharmacology

Background:

  • Multiple sclerosis (MS) is a central nervous system demyelinating disease with unknown causes.
  • Current treatments like interferon-beta and glatiramer acetate have limited efficacy in slowing long-term disability.
  • There is a significant unmet need for therapies that can halt, reverse, or prevent MS development.

Purpose of the Study:

  • To review current multiple sclerosis therapies.
  • To describe innovative strategies for altering the disease course.
  • To highlight the potential of new technologies in MS treatment and diagnostics.

Main Methods:

  • Review of existing multiple sclerosis treatments.
  • Exploration of emerging therapeutic strategies.

Related Experiment Videos

  • Discussion of advancements in gene expression profiling, genomics, and proteomics.

    • Main Results:

    • Current MS therapies offer limited long-term benefits.
    • Innovative strategies are under development to modify MS disease progression.
    • Gene expression profiling, genomics, and proteomics show promise for future MS treatments and diagnostics.

    Conclusions:

    • Novel therapeutic approaches are crucial for effectively managing multiple sclerosis.
    • Advanced technologies like genomics and proteomics are expected to yield new treatments and diagnostic tools.
    • These fields may elucidate the mechanisms underlying MS initiation and progression.